Central Valley Advisors LLC Buys 47 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Central Valley Advisors LLC grew its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 1.4% in the third quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 3,514 shares of the healthcare conglomerate’s stock after acquiring an additional 47 shares during the period. UnitedHealth Group comprises 1.2% of Central Valley Advisors LLC’s investment portfolio, making the stock its 22nd biggest position. Central Valley Advisors LLC’s holdings in UnitedHealth Group were worth $2,054,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors have also bought and sold shares of the company. Eldred Rock Partners LLC lifted its stake in shares of UnitedHealth Group by 4.4% during the 3rd quarter. Eldred Rock Partners LLC now owns 20,149 shares of the healthcare conglomerate’s stock valued at $11,780,000 after buying an additional 843 shares in the last quarter. Lwmg LLC raised its stake in UnitedHealth Group by 50.6% in the third quarter. Lwmg LLC now owns 2,287 shares of the healthcare conglomerate’s stock valued at $1,337,000 after purchasing an additional 768 shares in the last quarter. Thrive Wealth Management LLC increased its holdings in shares of UnitedHealth Group by 4.2% in the 3rd quarter. Thrive Wealth Management LLC now owns 1,924 shares of the healthcare conglomerate’s stock worth $1,125,000 after buying an additional 78 shares during the last quarter. AMI Investment Management Inc. lifted its holdings in shares of UnitedHealth Group by 2.0% during the 3rd quarter. AMI Investment Management Inc. now owns 5,061 shares of the healthcare conglomerate’s stock worth $2,959,000 after acquiring an additional 99 shares during the last quarter. Finally, Peoples Bank KS purchased a new stake in UnitedHealth Group during the third quarter valued at about $983,000. Hedge funds and other institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Stock Performance

Shares of NYSE UNH traded down $1.55 during trading on Friday, reaching $591.20. 2,463,201 shares of the company traded hands, compared to its average volume of 3,965,528. The stock has a market capitalization of $544.13 billion, a PE ratio of 36.14, a P/E/G ratio of 1.65 and a beta of 0.58. The firm has a 50 day simple moving average of $582.24 and a 200-day simple moving average of $527.36. UnitedHealth Group Incorporated has a 52-week low of $436.38 and a 52-week high of $607.94. The company has a quick ratio of 0.88, a current ratio of 0.88 and a debt-to-equity ratio of 0.67.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Tuesday, July 16th. The healthcare conglomerate reported $6.80 EPS for the quarter, topping the consensus estimate of $6.66 by $0.14. UnitedHealth Group had a return on equity of 26.55% and a net margin of 3.66%. The company had revenue of $98.86 billion during the quarter, compared to analyst estimates of $98.73 billion. During the same quarter in the previous year, the company posted $6.14 earnings per share. UnitedHealth Group’s revenue was up 6.4% compared to the same quarter last year. Equities research analysts anticipate that UnitedHealth Group Incorporated will post 27.69 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, September 24th. Investors of record on Monday, September 16th were paid a dividend of $2.10 per share. The ex-dividend date was Monday, September 16th. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.42%. UnitedHealth Group’s dividend payout ratio (DPR) is presently 51.34%.

Analyst Ratings Changes

Several analysts have issued reports on the company. Robert W. Baird upped their target price on UnitedHealth Group from $597.00 to $640.00 and gave the stock an “outperform” rating in a research note on Wednesday, July 17th. Jefferies Financial Group raised UnitedHealth Group from a “hold” rating to a “buy” rating and boosted their target price for the company from $481.00 to $647.00 in a research note on Wednesday, July 17th. Cantor Fitzgerald reiterated an “overweight” rating and issued a $591.00 price objective on shares of UnitedHealth Group in a research report on Tuesday. Morgan Stanley increased their price target on shares of UnitedHealth Group from $595.00 to $615.00 and gave the company an “overweight” rating in a research report on Wednesday, July 17th. Finally, Argus increased their target price on shares of UnitedHealth Group from $570.00 to $600.00 and gave the stock a “buy” rating in a report on Wednesday, July 17th. Two research analysts have rated the stock with a hold rating, eighteen have issued a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $614.17.

Insiders Place Their Bets

In related news, EVP Erin Mcsweeney sold 1,500 shares of the stock in a transaction dated Thursday, July 18th. The stock was sold at an average price of $579.03, for a total transaction of $868,545.00. Following the completion of the sale, the executive vice president now owns 7,785 shares in the company, valued at approximately $4,507,748.55. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. In related news, EVP Erin Mcsweeney sold 1,500 shares of the company’s stock in a transaction on Thursday, July 18th. The shares were sold at an average price of $579.03, for a total transaction of $868,545.00. Following the sale, the executive vice president now owns 7,785 shares of the company’s stock, valued at $4,507,748.55. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, CAO Thomas E. Roos sold 2,851 shares of the business’s stock in a transaction that occurred on Wednesday, July 17th. The stock was sold at an average price of $569.88, for a total value of $1,624,727.88. Following the sale, the chief accounting officer now directly owns 29,501 shares in the company, valued at $16,812,029.88. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 0.33% of the stock is owned by company insiders.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.